Inizio contenuto principale del sito

Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient Open new browser tab

(2021)

Aimo, A.; Saccaro, L. F.; Borrelli, C.; Fabiani, I.; Gentile, F.; Passino, C.; Emdin, M.; Piepoli, M. F.; Coats, A. J. S.; Giannoni, A.

The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease Open new browser tab

(2021)

Vergaro, G.; Aimo, A.; Taurino, E.; Del Franco, A.; Fabiani, I.; Prontera, C.; Masotti, S.; Musetti, V.; Emdin, M.; Passino, C.

Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure Open new browser tab

(2021)

Ghionzoli, N.; Gentile, F.; Del Franco, A. M.; Castiglione, V.; Aimo, A.; Giannoni, A.; Burchielli, S.; Cameli, M.; Emdin, M.; Vergaro, G.

Current and emerging drug targets in heart failure treatment Open new browser tab

(2021)

Vergaro, G.; Castiglione, V.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Giannelli, E.; Maltinti, M.; Passino, C.; Emdin, M.

Biomarkers for the diagnosis and management of heart failure: New frontiers Open new browser tab

(2021)

Aimo, A.; Pelliccia, F.; Panichella, G.; Vergaro, G.; Barison, A.; Passino, C.; Emdin, M.; Camici, P. G.

Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity Open new browser tab

(2021)

Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M.

A simple echocardiographic score to rule out cardiac amyloidosis Open new browser tab

(2021)